To identify predictors of when systematic biopsy leads to a higher overall prostate cancer grade compared to targeted biopsy.

918 consecutive patients who underwent prostate MRI followed by MRI/US fusion biopsy and systematic biopsies from January 2015 to November 2019 at a single academic medical center were retrospectively identified.

X